We are live on ! Find out more
CM

Capital Management Portfolio holdings

AUM $585M
1-Year Est. Return 5.18%
This Fund
S&P 500
This Quarter Est. Return
+0.9%
1 Year Est. Return
+5.18%
3 Year Est. Return
+40.88%
5 Year Est. Return
+39.5%
10 Year Est. Return
+202.53%
AUM
$587M
AUM Growth
+$9.64M
Cap. Flow
+$11.6M
Cap. Flow %
1.98%
Top 10 Hldgs %
39.05%
Holding
83
New
5
Increased
24
Reduced
30
Closed
3

Top Sells

Rank Stock Value
1
VRN
Veren
VRN
+$17.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$6.09M
3
TAP icon
Molson Coors Class B
TAP
+$4.12M
4
CAG icon
Conagra Brands
CAG
+$3.22M
5
EXEL icon
Exelixis
EXEL
+$3.05M

Sector Composition

Rank Sector Weight
1 Financials 22.65%
2 Communication Services 19.99%
3 Industrials 16.33%
4 Technology 13.69%
5 Energy 5.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEP icon
76
PepsiCo
PEP
$195B
$214K 0.04%
1,619
XOM icon
77
ExxonMobil
XOM
$634B
$209K 0.04%
1,940
-118
-6% -$12.6K
VGK icon
78
Vanguard FTSE Europe ETF
VGK
$30.2B
$207K 0.04%
+2,675
New +$197K
EPS icon
79
WisdomTree US LargeCap Fund
EPS
$1.58B
$206K 0.04%
3,225
-200
-6% -$11.9K
COF icon
80
Capital One
COF
$130B
$204K 0.03%
+957
New +$179K
ABBV icon
81
AbbVie
ABBV
$465B
-1,056
Closed -$221K
AMZN icon
82
Amazon
AMZN
$2.48T
-1,560
Closed -$297K
VRN
83
DELISTED
Veren
VRN
-2,586,194
Closed -$17.1M

Similar funds

Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Capital Management held 83 positions worth $587M, up 1.7% from $577M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Capital Management's Q2 2025 filing shows 5 new, 24 increased, 30 reduced and 3 closed positions. Its largest new stake was Concentrix: 325,993 shares worth $17.2M. The largest sale was Veren, an estimated $17.1M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 21% a quarter earlier, followed by Communication Services and Industrials.

  • Capital Management's largest Q2 2025 buy was Concentrix: 325,993 shares worth $17.2M.
  • Capital Management added most to LifeVantage in Q2 2025, an estimated $7.12M increase.
  • Capital Management's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $6.09M.
  • Capital Management fully exited Veren in Q2 2025, selling an estimated $17.1M.
  • Capital Management's ten largest holdings make up 39% of its $587M portfolio in Q2 2025.
  • Capital Management opened 5 new positions and closed 3 in Q2 2025.
  • Capital Management's portfolio value rose 1.7% quarter-over-quarter to $587M.

Based on Capital Management's 13F filing for Q2 2025, filed 28 Jul 2025.